Euclidean Technologies Management, LLC

Investment decisions are led by CEO and co-founder John R. Chisholm, who previously worked at D.E. Shaw and Two Sigma. Chairman James O'Shaughnessy provides strategic oversight and contributes decades of systematic value research (public record).

Euclidean does not source traditional deal flow; it applies machine learning to public datasets — including financial statements, price history, and alternative data — to generate tradeable signals. The firm's edge lies in its algorithms rather than proprietary access to private companies.

Euclidean manages a direct investment fund that allocates capital according to its systematic equity strategy. The firm does not act as a fund-of-funds or commit to external managers; its portfolio consists of publicly traded securities.

Euclidean invests across large-cap and mid-cap public equities, focusing on companies with measurable fundamentals. It does not target venture-stage or early-growth private companies.

Euclidean does not publicly disclose sector restrictions. However, its quantitative strategy applies a value-and-momentum framework that may underweight high-valuation growth sectors such as early-stage biotech or pre-revenue tech.

James O'Shaughnessy serves as chairman of Euclidean Technologies, but the firm operates independently from his family office and venture firm OSVC. Euclidean is a separate legal entity with its own management and investment mandate.

Euclidean does not engage in co-investments alongside external general partners. Its investment model is based on systematic public market strategies, not partnership or club-deal structures.